For: | Sachdeva M, Chawla YK, Arora SK. Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection. World J Hepatol 2015; 7(19): 2202-2208 [PMID: 26380045 DOI: 10.4254/wjh.v7.i19.2202] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i19/2202.htm |
Number | Citing Articles |
1 |
Jijing Shi, Yuanyuan Li, Wenxian Chang, Xuexiu Zhang, Fu-Sheng Wang. Current progress in host innate and adaptive immunity against hepatitis C virus infection. Hepatology International 2017; 11(4): 374 doi: 10.1007/s12072-017-9805-2
|
2 |
Janine Kemming, Robert Thimme, Christoph Neumann-Haefelin. Adaptive Immune Response against Hepatitis C Virus. International Journal of Molecular Sciences 2020; 21(16): 5644 doi: 10.3390/ijms21165644
|
3 |
Dina Ragab, Dalia Samaha, Nesrine Mohamed, Mona Rafik, Walid Abdel Hady. Chronic hepatitis C virus infection impairs natural killer cells–dendritic cells cross‐talk: Anin vitroculture study. Microbiology and Immunology 2021; 65(2): 76 doi: 10.1111/1348-0421.12858
|
4 |
Sabrina Mazouz, Maude Boisvert, Naglaa H Shoukry, Daniel Lamarre. Reversing immune dysfunction and liver damage after direct-acting antiviral treatment for hepatitis C. Canadian Liver Journal 2018; 1(2): 78 doi: 10.3138/canlivj.1.2.007
|
5 |
Mohamed M. Nabeel, Rania K. Darwish, Wafaa Alakel, Rabab Maher, Hossam Mostafa, Ahmed Hashem, Mohamed Elbeshlawy, Amr Abul-Fotouh, Hend I. Shousha, Mohamad Saeed Marie. Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot Study. Journal of Clinical and Experimental Hepatology 2022; 12(2): 428 doi: 10.1016/j.jceh.2021.06.018
|
6 |
Basma Abdulsamad, Mohamed Afifi, Ashraf K. Awaad, Waleed Elbendary, Hanan Mustafa, Bassem Elsherbini. Effect of Direct Acting Antivirals (DAAs) on Myeloid-Derived Suppressor Cells Population in Egyptian Chronic Hepatitis C Virus Patients: A Potential Immunomodulatory Role of DAAs. Viral Immunology 2023; 36(4): 259 doi: 10.1089/vim.2022.0170
|
7 |
Elena Chernykh, Olga Leplina, Ekaterina Oleynik, Marina Tikhonova, Tamara Tyrinova, Natalia Starostina, Alexandr Ostanin. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial). Immunologic Research 2018; 66(1): 31 doi: 10.1007/s12026-017-8967-2
|
8 |
Srikanta Dash, Yucel Aydin, Kyle E Widmer, Leela Nayak. <p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>. Journal of Hepatocellular Carcinoma 2020; : 45 doi: 10.2147/JHC.S221187
|
9 |
Sunil K. Arora. Meet the Editorial Board Member. Current HIV Research 2022; 20(3): 199 doi: 10.2174/1570162X2003220913151824
|
10 |
E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, T. V. Tyrinova, N. M. Starostina, A. A. Ostanin. Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-α. Russian Journal of Infection and Immunity 2019; 9(1): 76 doi: 10.15789/2220-7619-2019-1-76-86
|